| 1 | actin-myosin filament sliding (GO:0033275) | 9.11058974 |
| 2 | muscle filament sliding (GO:0030049) | 9.11058974 |
| 3 | sarcomere organization (GO:0045214) | 8.60694537 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 8.21871609 |
| 5 | actin-mediated cell contraction (GO:0070252) | 7.43830920 |
| 6 | myofibril assembly (GO:0030239) | 7.41439447 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.36670913 |
| 8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.18561972 |
| 9 | cardiac myofibril assembly (GO:0055003) | 7.14297702 |
| 10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.10461911 |
| 11 | skeletal muscle fiber development (GO:0048741) | 6.97892373 |
| 12 | plasma membrane repair (GO:0001778) | 6.86010003 |
| 13 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.72989823 |
| 14 | skeletal muscle contraction (GO:0003009) | 6.54542271 |
| 15 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.28078972 |
| 16 | myotube cell development (GO:0014904) | 6.26582439 |
| 17 | cardiac muscle contraction (GO:0060048) | 6.23116263 |
| 18 | striated muscle contraction (GO:0006941) | 6.13648232 |
| 19 | tricarboxylic acid cycle (GO:0006099) | 6.12836151 |
| 20 | carnitine shuttle (GO:0006853) | 5.97092111 |
| 21 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.86363455 |
| 22 | regulation of cell communication by electrical coupling (GO:0010649) | 5.84180976 |
| 23 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.82104175 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 5.81914054 |
| 25 | actin filament-based movement (GO:0030048) | 5.59502593 |
| 26 | actomyosin structure organization (GO:0031032) | 5.54155025 |
| 27 | cardiac muscle cell development (GO:0055013) | 5.42494821 |
| 28 | skeletal muscle adaptation (GO:0043501) | 5.41534951 |
| 29 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.40777021 |
| 30 | regulation of actin filament-based movement (GO:1903115) | 5.33943594 |
| 31 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.33044985 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.25416485 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 5.06420641 |
| 34 | cardiac cell development (GO:0055006) | 5.06101006 |
| 35 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.05305088 |
| 36 | creatine metabolic process (GO:0006600) | 5.01518761 |
| 37 | regulation of coenzyme metabolic process (GO:0051196) | 4.89210506 |
| 38 | regulation of cofactor metabolic process (GO:0051193) | 4.89210506 |
| 39 | skeletal muscle tissue development (GO:0007519) | 4.86641987 |
| 40 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.78191371 |
| 41 | cardiac muscle hypertrophy (GO:0003300) | 4.76059356 |
| 42 | heart process (GO:0003015) | 4.75816505 |
| 43 | heart contraction (GO:0060047) | 4.75816505 |
| 44 | striated muscle hypertrophy (GO:0014897) | 4.65113051 |
| 45 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.62210433 |
| 46 | regulation of striated muscle contraction (GO:0006942) | 4.57347135 |
| 47 | skeletal muscle tissue regeneration (GO:0043403) | 4.56549401 |
| 48 | glycogen catabolic process (GO:0005980) | 4.49782296 |
| 49 | regulation of sarcomere organization (GO:0060297) | 4.47627567 |
| 50 | adult heart development (GO:0007512) | 4.41586607 |
| 51 | muscle contraction (GO:0006936) | 4.40141495 |
| 52 | carnitine transmembrane transport (GO:1902603) | 4.37631890 |
| 53 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.34805434 |
| 54 | regulation of membrane repolarization (GO:0060306) | 4.34287935 |
| 55 | muscle tissue morphogenesis (GO:0060415) | 4.27439577 |
| 56 | positive regulation of myotube differentiation (GO:0010831) | 4.26283586 |
| 57 | fructose metabolic process (GO:0006000) | 4.25294580 |
| 58 | response to inactivity (GO:0014854) | 4.18765608 |
| 59 | glucan catabolic process (GO:0009251) | 4.18638349 |
| 60 | muscle organ morphogenesis (GO:0048644) | 4.17620954 |
| 61 | striated muscle adaptation (GO:0014888) | 4.13783220 |
| 62 | glycogen metabolic process (GO:0005977) | 4.09134421 |
| 63 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.08444636 |
| 64 | muscle hypertrophy (GO:0014896) | 4.08106984 |
| 65 | oxidative phosphorylation (GO:0006119) | 4.05485073 |
| 66 | muscle organ development (GO:0007517) | 4.03681799 |
| 67 | muscle structure development (GO:0061061) | 4.03279152 |
| 68 | heart trabecula formation (GO:0060347) | 4.03121471 |
| 69 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.02172751 |
| 70 | muscle system process (GO:0003012) | 4.01800636 |
| 71 | muscle cell fate commitment (GO:0042693) | 4.01517386 |
| 72 | cellular glucan metabolic process (GO:0006073) | 4.01072334 |
| 73 | glucan metabolic process (GO:0044042) | 4.01072334 |
| 74 | carnitine transport (GO:0015879) | 3.96294099 |
| 75 | amino-acid betaine transport (GO:0015838) | 3.96294099 |
| 76 | gluconeogenesis (GO:0006094) | 3.95578553 |
| 77 | NADH metabolic process (GO:0006734) | 3.95500809 |
| 78 | response to muscle activity (GO:0014850) | 3.94641931 |
| 79 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.92537294 |
| 80 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.90331605 |
| 81 | response to activity (GO:0014823) | 3.89538721 |
| 82 | cellular polysaccharide catabolic process (GO:0044247) | 3.89419194 |
| 83 | regulation of sulfur metabolic process (GO:0042762) | 3.87961016 |
| 84 | striated muscle cell development (GO:0055002) | 3.83419421 |
| 85 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.82867268 |
| 86 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.82867268 |
| 87 | cytidine deamination (GO:0009972) | 3.79928471 |
| 88 | cytidine metabolic process (GO:0046087) | 3.79928471 |
| 89 | cytidine catabolic process (GO:0006216) | 3.79928471 |
| 90 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.79476848 |
| 91 | striated muscle atrophy (GO:0014891) | 3.79292509 |
| 92 | neuronal action potential propagation (GO:0019227) | 3.77717876 |
| 93 | respiratory electron transport chain (GO:0022904) | 3.72864260 |
| 94 | myoblast fusion (GO:0007520) | 3.71049564 |
| 95 | 2-oxoglutarate metabolic process (GO:0006103) | 3.68458225 |
| 96 | muscle fiber development (GO:0048747) | 3.67783748 |
| 97 | polysaccharide catabolic process (GO:0000272) | 3.66155150 |
| 98 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.65213295 |
| 99 | electron transport chain (GO:0022900) | 3.61895014 |
| 100 | muscle hypertrophy in response to stress (GO:0003299) | 3.58365018 |
| 101 | cardiac muscle adaptation (GO:0014887) | 3.58365018 |
| 102 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.58365018 |
| 103 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.56865620 |
| 104 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.56865620 |
| 105 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.54142776 |
| 106 | hexose biosynthetic process (GO:0019319) | 3.54128444 |
| 107 | regulation of the force of heart contraction (GO:0002026) | 3.53118026 |
| 108 | ATP synthesis coupled proton transport (GO:0015986) | 3.52356101 |
| 109 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.52356101 |
| 110 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.52054690 |
| 111 | IMP metabolic process (GO:0046040) | 3.51723265 |
| 112 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.51148901 |
| 113 | negative regulation of potassium ion transport (GO:0043267) | 3.50202737 |
| 114 | positive regulation of cation channel activity (GO:2001259) | 3.49865665 |
| 115 | glycogen biosynthetic process (GO:0005978) | 3.49136270 |
| 116 | glucan biosynthetic process (GO:0009250) | 3.49136270 |
| 117 | regulation of myoblast differentiation (GO:0045661) | 3.49113699 |
| 118 | negative regulation of muscle contraction (GO:0045932) | 3.47875858 |
| 119 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.45957854 |
| 120 | cell communication involved in cardiac conduction (GO:0086065) | 3.44866356 |
| 121 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.43800876 |
| 122 | cardiac muscle cell action potential (GO:0086001) | 3.42150746 |
| 123 | muscle cell development (GO:0055001) | 3.41661632 |
| 124 | muscle cell cellular homeostasis (GO:0046716) | 3.41101482 |
| 125 | muscle adaptation (GO:0043500) | 3.39554804 |
| 126 | muscle atrophy (GO:0014889) | 3.39463992 |
| 127 | regulation of sequestering of triglyceride (GO:0010889) | 3.38396225 |
| 128 | myotube differentiation (GO:0014902) | 3.38381578 |
| 129 | regulation of ATPase activity (GO:0043462) | 3.36801321 |
| 130 | neuromuscular synaptic transmission (GO:0007274) | 3.34129909 |
| 131 | relaxation of muscle (GO:0090075) | 3.30088086 |
| 132 | striated muscle tissue development (GO:0014706) | 3.30023194 |
| 133 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.24920243 |
| 134 | cellular carbohydrate catabolic process (GO:0044275) | 3.21395716 |
| 135 | ubiquinone biosynthetic process (GO:0006744) | 3.18984867 |
MYADML2 
